HomeAbout PERSConduct DisorderThe PERS studyPatients and relativesResources
About PERS Members SoP

School of Pharmacy, University of London


The Centre for Paediatric Pharmacy Research,
The School of Pharmacy, University of London,
BMA / Tavistock House,
Entrance A, 1st Floor,
Tavistock Square,


Project leader

Professor Ian Chi Kei Wong

Professor Ian Chi Kei Wong


Project staff

Dr. Macey Murray


Institute presentation

Description of organisation

The School of Pharmacy (SoP) is dedicated to teaching and research in pharmacy and pharmaceutics. Within SoP the Centre for Paediatric Pharmacy Research (CPPR) was established in April 2002 in collaboration with the Institute of Child Health and Great Ormond Street Hospital for Children. The aim of the Centre is to improve paediatric medicines, in particular, its quality, safety, efficacy and ethical policy. In addition, the specialist resources of universities and hospitals nationwide are utilised collaboratively to provide a focus for the training of health care professionals in the optimum use of medicines for children. It is the first center of its kind established in the UK.

Previous experience

The Centre has a comprehensive expertise in paediatric drug safety and pharmacoepidemiology particularly in the area of paediatric neuropsychopharmacology. It has been conducting research in these areas since it was established in 2002. Prof Ian Wong and his team have been involved in many national and international collaborations either as principal applicant or UK-Coordinator such as the EU-commissioned “Task Force in Europe for Drug Development in the Young” (TEDDY) and the “CHildren and Adolescents Psychiatric pharmaco-Therapy Evaluation Research” (CHAPTER) or “Cessation of Attention deficit hyperactivity Disorder Drugs in Young” (CADDY) both funded by the Department of Health in England.

Profile of staff members

Professor Ian Wong is Professor of Paediatric Pharmacy and Director of the Centre for Paediatric Pharmacy Research at the School of Pharmacy, University of London. He is the Chair of the Pharmacy and Pharmacology Clinical Study Group of the newly-formed Medicines for Children Research Network (MCRN) and the Coordinator of the Long-term Effects of Psychotropic Medication in Children Research Group of the Department of Health Mental Health Research Network. He has received the UK Department of Health Public Health Career Scientist Award obtained over £2.5 million in research grants as the principal applicant and approximately £8 million as a co-applicant. Prof Wong has published over 80 publications and is also working with pharmaceutical companies to conduct clinical trials studies for paediatric licensing applications.

Mrs Macey Murray is a Senior Research Fellow, she has seven years’ experience of working in phase I-III clinical trials, from inception to the management of data for statistical analysis.  She spent five years as a trial coordinator and data manager for an international phase III chemotherapy trial in early breast cancer prior to joining the CPPR. Macey Murray's has been studying the use and safety of psychotropic medications in children and adolescents since joining the CPPR in 2003.

Dr Antje Neubert is a Senior Research Fellow at CPPR. She also works as a Clinical Research Scientist for a Pharmaceutical Company being involved in the preparation of clinical documents related to regulatory aspects of medicines.

Dr Mine Gul is a formulation research fellow. Dr Gul is funded by the UK Medicines for Children Research Network to deal with formulation and clinical trial material supply of different paediatric medicines clinical trials conducted in the Network.